
Gamma-Delta T Cells Identified as Key to Defeating Small Cell Lung Cancer
Researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI) have identified gamma-delta T cells as a potent immune defense against small cell lung cancer (SCLC), a disease with less than 7% five-year survival. Published in Cancer Cell, the study shows these cells can detect and destroy SCLC tumors that evade conventional immune responses. When combined with existing drugs tarlatamab and zoledronate, the efficacy of these immune cells increases significantly. The findings suggest new treatment strategies, including adoptive cell transfer, and indicate that gamma-delta T cell levels may predict patient response to immunotherapy.


